AzTrials
AzTrials

AnxietyNCT04049201

Interactive Tablet Compared to Oral Midazolam as Premedication in Preoperative Anxiety in Children

A study testing elective surgery, Midazolam and Interactive Tablet in people with Anxiety, run by Hôpital d'enfants Béchir-Hamza at 1 site in Tunisia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

preoperative anxiety is an undesirable outcome in pediatric surgical patients.It can lead to behavioral trouble such as enuresis, apathy and sleep disorders. to prevent this anxiety,many tools can be used for premedication like pharmacological:Midazolam, clonidine, hydroxysine or non pharmacological tools such as… Read more about this study

Who is it for?
Ages 3 to 10 years
Conditions the study is for
Anxiety
What is being tested?
elective surgery, Midazolam and Interactive Tablet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteTunisia
Study dates
4 May 2018to 19 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 3-10 years old children
  • elective surgery
  • ASA PS I/II

Who cannot join

  • Parental refusal
  • Emergency procedure
  • Behavioral or psychiatric disorders
  • allergy or hypersensitivity to midazolam

Trial locations and contacts

1 site in 1 country.

Tunisia1 site
  • Hopital d'Enfants Bechir Hamza

    Tunis, 1029

Other trials in Tunisia

About this study

preoperative anxiety is an undesirable outcome in pediatric surgical patients.It can lead to behavioral trouble such as enuresis, apathy and sleep disorders.

to prevent this anxiety,many tools can be used for premedication like pharmacological:Midazolam, clonidine, hydroxysine or non pharmacological tools such as parental presence,hypnosis and interactive tablet.

the purpose of the study is to compare the effect of interactive tablet to oral midazolam.on preoperative anxiety in children prior to elective surgery

Read the detailed description

this study is a prospective,randomized, active treatment controlled trial.It enrolls 100 children .

after written and informed consent,the study participants were randomly assigned using a computer generated table to one of two treatment groups prior to elective surgery.

Group T: will receive an interactive tablet containing many cartoon's videos 20 minutes before the parental separation and until the anesthesia induction Group MD:will receive oral midazolam 20 minutes before parental separation with 0.5 mg/kg (max 20mg) Anxiety assessement was done using the Modified Yale Perioperative Anxiety Scale( MYPAS) at the separation of parents,the admission in the operating room and the anesthesia induction.

Facial mask acceptance,post operative agitation (PAEDS score: Pediatric Anesthesia Emergence of Delirium) and parental satisfaction were also assessed.

Conditions
Anxiety
Being tested
elective surgery, Midazolam, Interactive Tablet
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • elective surgeryProcedure or surgery

    Also called we will study the acceptance of the facial mask,the post operative delirium and the parents satisfaction

    investigators will compare the effect of interactive tablet on preoperative anxiety in children to the effect ofMidazolam in elective surgery

  • MidazolamDrug

    Oral Midazolam

  • Interactive TabletDevice

    interactive Tablet containing many cartoon's videos

Study groups in NCT04049201
Study groupRoleWhat they receive
Group tabletExperimentalgroup T will receive interactive Tablet containing many cartoon's videos 20 minutes before parental separation until the anesthesia induction
Receives: Procedure: elective surgery; Device: Interactive Tablet
Group MidazolamActive comparatorgroup Midazolam will receive oral midazolam 0.5 mg/kg (max 20 mg) 20 minutes before the parental separation
Receives: Procedure: elective surgery; Drug: Midazolam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preoperative anxiety

    preoperative anxiety will be measured by the modified Yale Perioperative Anxiety Scale (MYPAS)at different time prior to elective surgery .the averaged score range from 24.9: no anxiety to 100 very anxious

    Measured: 20 minutes after tablet was given

  2. Preoperative anxiety

    preoperative anxiety will be measured by the modified Yale Perioperative Anxiety Scale(MYPAS)at different time prior to elective surgery .the averaged score ranges from 24.9 no anxiety to 100 very anxious

    Measured: 25 minutes after tablet was given

  3. Preoperative anxiety

    preoperative anxiety will be measured by the modified Yale Perioperative Anxiety Scale(MYPAS)at different time prior to elective surgery.the averaged score range from 24.9 no anxiety to 100 very anxious

    Measured: 30 minutes after tablet was given

Secondary outcomes (3)
  1. the acceptance of Facial mask

    the acceptance of facial mask by an established score

    Measured: 30 minutes after tablet was given

  2. post operative agitation

    post operative agitation was assessed using PAEDS which was calculated 10 to 15 minutes after the anesthetic wake up.

    Measured: 10 to 15 minutes after wakeup of anesthesia

  3. the parental satisfaction

    by an established score

    Measured: 1 hour after the wake up of anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2019
  2. Study start4 May 2018
  3. Primary completion19 May 2019
  4. Study completion19 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
112 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04049201
Sponsor's protocol ID
02/2019
Status last verified
May 2019
First submitted
18 Mar 2019
Last updated
8 Aug 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing elective surgery, Midazolam and Interactive Tablet in people with Anxiety, run by Hôpital d'enfants Béchir-Hamza at 1 site in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preoperative anxiety (time frame: 20 minutes after tablet was given). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2019; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in